Skip to main content

Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

Clinical Info HIV.gov logo
In affiliation with HIV.gov

Main navigation

  • Home
  • Guidelines
  • Drug Database
  • Glossary
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Guidelines
  3. Perinatal

Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Guidelines search

  • Adult and Adolescent ARV (20)
  • Adult and Adolescent Opportunistic Infection (33)
  • Caring for Persons with HIV in Disaster Areas (4)
  • COVID-19 and Persons with HIV (Interim Guidance) (1)
  • Pediatric ARV (17)
  • Pediatric Opportunistic Infection (31)
  • Perinatal (16)
Version:
Brief Full
What's New in the Guidelines Guidelines Panel Members Financial Disclosure Introduction Maternal HIV Testing and Identification of Perinatal HIV Exposure Pre-exposure Prophylaxis (PrEP) to Reduce the Risk of Acquiring HIV During Periconception, Antepartum, and Postpartum Periods
Overview
Reproductive Options for Couples When One or Both Partners Have HIV
Overview
Teratogenicity
Antiretroviral Drug Regimens and Maternal and Neonatal Outcomes
Overview
Pregnant People with HIV Who Have Never Received Antiretroviral Drugs
Table 4. What to Start: Initial Combination Regimens for Antiretroviral-Naive Pregnant Women
Table 5. Situation-Specific Recommendations for Use of ARVs
Pregnant Women with HIV Who Are Currently Receiving Antiretroviral Therapy
Pregnant Women with HIV Who Have Previously Received Antiretroviral Treatment or Prophylaxis but Are Not Currently Receiving Any Antiretroviral Medications
Monitoring of the Woman and Fetus During Pregnancy
Antiretroviral Drug Resistance and Resistance Testing in Pregnancy
Women Who Have Not Achieved Viral Suppression on Antiretroviral Therapy
Stopping Antiretroviral Drugs During Pregnancy
Hepatitis B Virus/HIV Coinfection
Hepatitis C Virus/HIV Coinfection
HIV-2 Infection and Pregnancy
Prenatal Care, Antiretroviral Therapy, and HIV Management in Women with Perinatal HIV Infection
Acute HIV Infection
Intrapartum Care for Women with HIV Postpartum Follow-Up of Women with HIV Counseling and Management of Women with HIV Who Breastfeed
Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection
Diagnosis of HIV Infection in Infants and Children
Initial Postnatal Management of the Neonate Exposed to HIV
Long-Term Follow-Up of Infants Exposed to Antiretroviral Drugs
Appendix A: Review of Clinical Trials of Antiretroviral Interventions to Prevent Perinatal HIV Transmission
Table 10. ARV Drug Use in Pregnant Women with HIV
Overview
Abacavir (Ziagen, ABC)
Emtricitabine (Emtriva, FTC)
Lamivudine (Epivir, 3TC)
Tenofovir Alafenamide (Vemlidy, TAF)
Tenofovir Disoproxil Fumarate (Viread, TDF)
Zidovudine (Retrovir, ZDV)
Doravirine (Pifeltro, DOR)
Efavirenz (Sustiva, EFV)
Etravirine (Intelence, ETR)
Nevirapine (Viramune, NVP)
Rilpivirine (Edurant, RPV)
Atazanavir (Reyataz, ATV)
Darunavir (Prezista, DRV)
Lopinavir/Ritonavir (Kaletra, LPV/r)
Ibalizumab-uiyk (Trogarzo, IBA)
Maraviroc (Selzentry, MVC)
Fostemsavir (Rukobia, FTR)
Bictegravir (BIC)
Dolutegravir (Tivicay, DTG)
Elvitegravir (EVG)
Raltegravir (Isentress, RAL)
Cobicistat (Tybost, COBI)
Ritonavir (Norvir, RTV)
Overview
Amprenavir (Agenerase, APV)
Delavirdine (Rescriptor, DLV)
Didanosine (Videx, ddI)
Enfuvirtide (Fuzeon, T-20)
Fosamprenavir (Lexiva, FPV)
Indinavir (Crixivan, IDV)
Nelfinavir (Viracept, NFV)
Saquinavir (Invirase, SQV)
Stavudine (Zerit, d4T)
Tipranavir (Aptivus, TPV)
Zalcitabine (Hivid, ddC)
Antiretroviral Pregnancy Registry
Appendix C: Antiretroviral Counseling Guide for Health Care Providers Appendix D. Acronyms

Download Guidelines

  • Section OnlyPDF (745.26 KB)
  • Full GuidelinePDF (2.76 MB)
  • Recommendations OnlyPDF (313.35 KB)
  • Tables OnlyPDF (572.94 KB)

Related Content

  • Clinical Info Drug Database
  • Clinical Info Patient Materials: Preventing Mother-to-Child Transmission of HIV
  • Clinical Info Patient Materials: HIV Medicines During Pregnancy and Childbirth
  • Clinical Info Patient Materials: Protecting Baby from HIV
  • AETC National HIV Curriculum
  • How to Cite These Guidelines
  • Guidelines Archive

Appendix D. Acronyms

Updated
Oct. 26, 2016
Reviewed
Oct. 26, 2016

View full version of Appendix D
Appendix D. Acronyms
   
   
   
   

View full version of Appendix D
Appendix D. Acronyms
   
   
   
   

Download Guidelines

  • Section OnlyPDF (745.26 KB)
  • Full GuidelinePDF (2.76 MB)
  • Recommendations OnlyPDF (313.35 KB)
  • Tables OnlyPDF (572.94 KB)

Related Content

  • Clinical Info Drug Database
  • Clinical Info Patient Materials: Preventing Mother-to-Child Transmission of HIV
  • Clinical Info Patient Materials: HIV Medicines During Pregnancy and Childbirth
  • Clinical Info Patient Materials: Protecting Baby from HIV
  • AETC National HIV Curriculum
  • How to Cite These Guidelines
  • Guidelines Archive

Connect with us

Facebook
Twitter
Instagram
Subscribe

Mobile Apps

Guidelines
Drug Database
Glossary

Footer menu

  • Home
  • About
  • News
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.